Simplex Trading
HARP

Simplex Trading’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Simplex Trading’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-374
Closed -$2K – 10278
2023
Q2 		$2K Buy
374
+285
+320% +$1.97K ﹤0.01% 8535
2023
Q1 		$0 Sell
89
-451
-84% -$3.79K ﹤0.01% 10537
2022
Q4 		$3K Sell
540
-10
-2% -$84 ﹤0.01% 8484
2022
Q3 		$5K Buy
550
+59
+12% +$1.1K ﹤0.01% 8850
2022
Q2 		$9K Buy
+491
New +$12.7K ﹤0.01% 8419
2022
Q1 		– Sell
-40
Closed -$2.07K – 11725
2021
Q4 		$3K Buy
+40
New +$2.73K ﹤0.01% 9913
2021
Q1 		– Sell
-485
Closed -$97.2K – 10355
2020
Q4 		$80K Buy
485
+354
+270% +$54.7K ﹤0.01% 5672
2020
Q3 		$22K Buy
+131
New +$18.9K ﹤0.01% 6314

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Simplex Trading's HARP Position: Q3 2023 in Review

Simplex Trading sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 374 shares — an estimated $2K sold.

Simplex Trading first reported a position in HARP in Q3 2020 and held it in 8 quarters. The position peaked at $80K in Q4 2020. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

  • Simplex Trading reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 374 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2K.
  • Simplex Trading first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Simplex Trading's Harpoon Therapeutics, Inc. Common Stock position peaked at $80K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.